ctrl K

Watchlist Price Alert

Kalaris Therapeutics Inc (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

2.81

0.14 (5.24%)

At close: Jun 17, 2025, 10:52 AM

Kalaris Therapeutics Inc Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a
Cost of Revenue	n/a	n/a
Gross Profit	n/a	n/a
Operating Income	-13.46M	-14.01M
Interest Income	n/a	n/a
Pretax Income	-14.7M	-15.48M
Net Income	-14.7M	-15.48M
Selling & General & Admin	1.76M	2.24M
Research & Development	11.71M	11.76M
Other Expenses	n/a	n/a
Operating Expenses	13.46M	14.01M
Interest Expense	687K	235K
Selling & Marketing Expenses	n/a	n/a
Cost & Expenses	13.46M	14.01M
Income Tax Expense	n/a	n/a
Shares Outstanding (Basic)	n/a	n/a
Shares Outstanding (Diluted)	n/a	n/a
EPS (Basic)	n/a	n/a
EPS (Diluted)	n/a	n/a
EBITDA	-14.01M	-15.25M
EBIT	-14.01M	-15.25M
Depreciation & Amortization	n/a	n/a